SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 27th, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement” ), dated as of February 24, 2009, by and between Alseres Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 239 South Street, Hopkinton, MA 01748 (the “Company” ), and Cato Holding Company, a North Carolina corporation dba Cato BioVentures (the “Investor” ).
February 24, 2009 Allen Cato, MD, PhD Cato BioVentures 4364 South Alston Avenue Durham, NC 27713 Ladies and Gentlemen:Securities Purchase Agreement • February 27th, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations
Contract Type FiledFebruary 27th, 2009 Company IndustryReference is hereby made to that certain Securities Purchase Agreement, of even date herewith, by and between Alseres Pharmaceuticals, Inc. (the “Company”) and the Investor listed therein (the “Purchase Agreement”). Capitalized terms not otherwise defined shall have the meaning ascribed to them in the Purchase Agreement.